A detailed history of Matrix Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Matrix Trust CO holds 113 shares of AMGN stock, worth $35,708. This represents 0.01% of its overall portfolio holdings.

Number of Shares
113
Holding current value
$35,708
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$309.38 - $337.38 $34,959 - $38,123
113 New
113 $36,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Matrix Trust CO Portfolio

Follow Matrix Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Matrix Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Matrix Trust CO with notifications on news.